- Home
- CNTX vs AUID Comparison
CNTX vs AUID Comparison
Compare CNTX & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- AUID
- Stock Information
- Founded
- CNTX 2015
- AUID 2009
- Country
- CNTX United States
- AUID United States
- Employees
- CNTX N/A
- AUID N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- AUID Computer Software: Prepackaged Software
- Sector
- CNTX Health Care
- AUID Technology
- Exchange
- CNTX Nasdaq
- AUID Nasdaq
- Market Cap
- CNTX 60.7M
- AUID 51.8M
- IPO Year
- CNTX 2021
- AUID N/A
- Fundamental
- Price
- CNTX $0.84
- AUID $8.07
- Analyst Decision
- CNTX Strong Buy
- AUID
- Analyst Count
- CNTX 5
- AUID 0
- Target Price
- CNTX $6.50
- AUID N/A
- AVG Volume (30 Days)
- CNTX 257.9K
- AUID 318.1K
- Earning Date
- CNTX 05-07-2025
- AUID 05-14-2025
- Dividend Yield
- CNTX N/A
- AUID N/A
- EPS Growth
- CNTX N/A
- AUID N/A
- EPS
- CNTX N/A
- AUID N/A
- Revenue
- CNTX N/A
- AUID $886,485.00
- Revenue This Year
- CNTX N/A
- AUID N/A
- Revenue Next Year
- CNTX N/A
- AUID N/A
- P/E Ratio
- CNTX N/A
- AUID N/A
- Revenue Growth
- CNTX N/A
- AUID 365.86
- 52 Week Low
- CNTX $0.55
- AUID $4.01
- 52 Week High
- CNTX $2.75
- AUID $12.31
- Technical
- Relative Strength Index (RSI)
- CNTX 56.99
- AUID 65.88
- Support Level
- CNTX $0.80
- AUID $5.00
- Resistance Level
- CNTX $0.89
- AUID $8.50
- Average True Range (ATR)
- CNTX 0.11
- AUID 1.12
- MACD
- CNTX 0.03
- AUID 0.29
- Stochastic Oscillator
- CNTX 73.80
- AUID 75.11
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises "Know Who's Behind the Device" for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric passwordless authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.